Epithelial cell specificity and apotope recognition by serum autoantibodies in primary biliary cirrhosis

Hepatology

Volumn 54, Issue 1, 2011, Pages 196-203

  Rong, Guanghua ^a,b   Zhong, Renqian ^b   Lleo, Ana ^a,c   Leung, Patrick S C ^a   Bowlus, Christopher L ^a   Yang, Guo Xiang ^a   Yang, Chen Yen ^a   Coppel, Ross L ^d   Ansari, Aftab A ^e   Cuebas, Dean A ^f   Worman, Howard J ^g   Invernizzi, Pietro ^a,c   Gores, Gregory J ^h   Norman, Gary ⁱ   He, Xiao Song ^a   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d MONASH UNIVERSITY   (Australia)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MISSOURI STATE UNIVERSITY   (United States)

^g Columbia University ^*  (United States)

^h MAYO CLINIC   (United States)

ⁱ INOVA DIAGNOSTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); 2,4 DIENOYL COENZYME A REDUCTASE (NADPH); ANTIGEN; APOTOPE; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; MITOCHONDRIAL ENZYME; MITOCHONDRIAL PROTEIN; PYRUVATE DEHYDROGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ACYLTRANSFERASES; ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; APOPTOSIS; AUTOANTIBODIES; BRONCHI; CASE-CONTROL STUDIES; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MAMMARY GLANDS, HUMAN; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS;

EID: 79959549320     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24355     Document Type: Article

References (52)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273.
2. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138: 3525-3531.
3. Van de Water J, Gerson LB, Ferrell LD, Lake JR, Coppel RL, Batts KP, et al. Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. Hepatology 1996; 24: 1079-1084.
4. Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 2009; 49: 871-879.
5. Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, Ansari AA, et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology 2010; 52: 987-998.
6. Kikuchi K. Immunoreactivity of recombinant human oxo-glutarate dehydrogenase complex (OGDC)-E2 protein in primary biliary cirrhosis. Hepatol Res 2000; 16: 211-223.
7. Moteki S, Leung P, Dickson E, Van Thiel D, Galperin C, Buch T, et al. Epitope mapping and reactivity of autoantibodies to the E2 component of 2 oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2 oxoglutarate dehydrogenase complex. Hepatology 1996; 23: 436-444.
8. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001; 34: 243-248.
9. Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 2007; 45: 659-665.
10. Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, et al. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Am J Gastroenterol 2003; 98: 431-437.
11. Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, et al. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 2010; 35: 436-442.
12. Agmon-Levin N, Shapira Y, Selmi C, Barzilai O, Ram M, Szyper-Kravitz M, et al. A comprehensive evaluation of serum autoantibodies in primary biliary cirrhosis. J Autoimmun 2010; 34: 55-58.
13. Hu CJ, Zhang FC, Li YZ, Zhang X. Primary biliary cirrhosis: what do autoantibodies tell us? World J Gastroenterol 2010; 16: 3616-3629.
14. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
15. Wiesner R, Grambsch P, Dickson E, Ludwig J, Maccarty R, Hunter E, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430-436.
16. Leung PS, Rossaro L, Davis PA, Park O, Tanaka A, Kikuchi K, et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 2007; 46: 1436-1442.
17. Migliaccio C, Nishio A, Van de Water J, Ansari A, Leung P, Nakanuma Y, et al. Monoclonal antibodies to mitochondrial E2 components define autoepitopes in primary biliary cirrhosis. J Immunol 1998; 161: 5157.
18. Greber UF, Senior A, Gerace L. A major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tail. EMBO J 1990; 9: 1495-1502.
19. Strain A, Wallace L, Joplin R, Daikuhara Y, Ishii T, Kelly D, et al. Characterization of biliary epithelial cells isolated from needle biopsies of human liver in the presence of hepatocyte growth factor. Am J Pathol 1995; 146: 537.
20. Yang Y, Raper S, Cohn J, Engelhardt J, Wilson J. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci U S A 1993; 90: 4601.
21. Drudi Metalli V, Mancino MG, Mancino A, Torrice A, Gatto M, Attili AF, et al. Bile salts regulate proliferation and apoptosis of liver cells by modulating the IGF1 system. Dig Liver Dis 2007; 39: 654-662.
22. Leung PS, Chuang DT, Wynn RM, Cha S, Danner DJ, Ansari A, et al. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 1995; 22: 505-513.
23. Nagata S, Hanayama R, Kawane K. Autoimmunity and the clearance of dead cells. Cell 2010; 140: 619-630.
24. Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2: 965-975.
25. Ravichandran K, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 2007; 7: 964-974.
26. Mahoney J, Rosen A. Apoptosis and autoimmunity. Current Opin Immunol 2005; 17: 583-588.
27. Chekeni FB, Ravichandran KS. The role of nucleotides in apoptotic cell clearance: implications for disease pathogenesis. J Mol Med 2011; 89: 13-22.
28. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol 2010; 6: 280-289.
29. Monks J, Rosner D, Geske F, Lehman L, Hanson L, Neville M, et al. Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ 2005; 12: 107-114.
30. Parnaik R, Raff M, Scholes J. Differences between the clearance of apoptotic cells by professional and non-professional phagocytes. Curr Biol 2000; 10: 857-860.
31. Gereke M, Jung S, Buer J, Bruder D. Alveolar type II epithelial cells present antigen to CD4+ T cells and induce Foxp3+ regulatory T cells. Am J Respir Crit Care Med 2009; 179: 344.
32. Fahey J, Wallace P, Johnson K, Guyre P, Wira C. Antigen presentation by human uterine epithelial cells to autologous T cells. Am J Reprod Immunol 2006; 55: 1-11.
33. Mulder DJ, Pooni A, Mak N, Hurlbut DJ, Basta S, Justinich CJ. Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis. Am J Pathol 2011; 178: 744-753.
34. Joplin R, Gershwin M. Ductular expression of autoantigens in primary biliary cirrhosis. Semin Liver Dis 1997; 17: 97-103.
35. Tsuneyama K, Van de Water J, Leung PS, Cha S, Nakanuma Y, Kaplan M, et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995; 21: 1031-1037.
36. Cha S, Leung PS, Van de Water J, Tsuneyama K, Joplin RE, Ansari AA, et al. Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2). Proc Natl Acad Sci U S A 1996; 93: 10949-10954.
37. Leung PS, Cha S, Joplin RE, Galperin C, Van de Water J, Ansari AA, et al. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes. J Autoimmun 1996; 9: 785-793.
38. Gregory CD, Pound JD. Microenvironmental influences of apoptosis in vivo and in vitro. Apoptosis 2010; 15: 1029-1049.
39. Bassendine MF, Dewar PJ, James OF. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut 1985; 26: 625-628.
40. Invernizzi P, Selmi C, Poli F, Frison S, Floreani A, Alvaro D, et al. Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis: a multicenter study of 664 patients and 1992 healthy controls. HEPATOLOGY 2008; 48: 1906-1912.
41. Juran BD, Atkinson EJ, Larson JJ, Schlicht EM, Lazaridis KN. Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis. Am J Gastroenterol 2009; 104: 1406-1411.
42. Kimura Y, Selmi C, Leung PS, Mao TK, Schauer J, Watnik M, et al. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. HEPATOLOGY 2005; 41: 55-63.
43. Wassmuth R, Depner F, Danielsson A, Hultcrantz R, Lööf L, Olson R, et al. HLA class II markers and clinical heterogeneity in Swedish patients with primary biliary cirrhosis. Tissue Antigens 2002; 59: 381-387.
44. Agarwal K, Jones DE, Daly AK, James OF, Vaidya B, Pearce S, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000; 32: 538-541.
45. Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Gu X, et al. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N Engl J Med 2009; 360: 2544-2555.
46. Liu X, Invernizzi P, Lu Y, Kosoy R, Bianchi I, Podda M, et al. Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet 2010; 42: 658-660.
47. Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008; 40: 395-402.
48. International Multiple Sclerosis Genetics Consortium (IMSGC). IL12A, MPHOSPH9/CDK2AP1 and RGS1 are novel multiple sclerosis susceptibility loci. Genes Immun 2010; 11: 397-405.
49. Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007; 357: 977-986.
50. Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005; 174: 5874-5883.
51. Alphey MS, Yu W, Byres E, Li D, Hunter WN. Structure and reactivity of human mitochondrial 2, 4-dienoyl-CoA reductase. J Biol Chem 2005; 280: 3068-3077.
52. Kita H, Matsumura S, He X, Ansari A, Lian Z, Van de Water J, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 2002; 109: 1231-1240.